With 1.61 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.8 million shares. The 52-week range on ENOV shows that it touched its highest point at $63.96 and its lowest point at $38.27 during that stretch. It currently has a 1-year price target of $63.89. Beta for the stock currently stands at 1.87.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ENOV was down-trending over the past week, with a drop of -10.19%, but this was down by -16.09% over a month. Three-month performance dropped to -13.36% while six-month performance fell -13.10%. The stock lost -36.36% in the past year, while it has lost -8.84% so far this year. A look at the trailing 12-month EPS for ENOV yields -2.17 with Next year EPS estimates of 3.69. For the next quarter, that number is 0.73. This implies an EPS growth rate of 12.03% for this year and 16.00% for next year.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ENOV since 4 analysts follow the stock currently. There are 4 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $2.78995 being high and $2.77003 being low. For ENOV, this leads to a yearly average estimate of $2.77999. Based on analyst estimates, the high estimate for the next quarter is $0.76 and the low estimate is $0.56. The average estimate for the next quarter is thus $0.71.
